NuvemRx

340B Technologies, Inc. , trading under the name NuvemRx, delivers innovative health technology solutions to enhance patient engagement and care management across healthcare providers and organizations. Founded in 2004, 340B Technologies, Inc. operates from Sharon Hill, US, offering a digital health platform that strengthens communication between healthcare providers and patients.

The CEO is Felipe de Paula Ferreira, and Paulo dos Santos plays a vital role in the company's leadership. Nuvem Health specializes in health technology solutions that enhance patient engagement and care management. Their offerings include a digital health platform that facilitates communication between healthcare providers and patients, improving treatment adherence and health outcomes. These solutions have been adopted by various healthcare organizations, such as hospitals, clinics, and telehealth providers, across North America and select European markets, effectively reaching patients with chronic conditions and those pursuing preventive care.

Nuvem Health generates revenue primarily through subscription-based models for its health technology services, which allow healthcare providers access to its digital platform. Clients, including hospitals and clinics, pay a recurring fee for the platform's features aimed at effective patient engagement. Revenue is further supported by direct agreements with healthcare organizations, often involving tiered pricing based on provider size and service range, where flagship products significantly contribute to the overall revenue stream. Looking ahead, NuvemRx plans to launch new products designed to further enhance their service offerings, although specific release dates have not been disclosed.

In July 2020, Parthenon Capital acquired Nuvem Health, as part of recapitalisation. The July 2020 acquisition enables Nuvem Health to accelerate growth initiatives and to provide liquidity to non-management shareholders.